Director

Joshua Salomon

Dr. Salomon is the Director of the Prevention Policy Modeling Lab.

He is a Professor of Health Policy in the Stanford University School of Medicine and a Senior Fellow at the Center for Health Policy in the Freeman Spogli Institute for International Studies. His research focuses on priority-setting in global health, within three main substantive areas: (1) measurement and valuation of health outcomes; (2) modeling patterns and trends in major causes of global mortality and disease burden; and (3) evaluation of health interventions and policies.

Dr. Salomon is an investigator on projects funded by the Centers for Disease Control, National Institutes of Health and the Bill & Melinda Gates Foundation, relating to modeling of infectious and chronic diseases and associated intervention strategies; methods for economic evaluation of public health programs; measurement of the global burden of disease; and assessment of the potential impact and cost-effectiveness of new health technologies.

Contact

See biography

Publications

Ferstad , J., Aslam , M., LY, W., Zhao, J., Li, J., & Salomon, J. (2024). State-level population estimates of sexual minority adolescents in the United States: A predictive modeling study. PloS One, 19(6), e0304175. https://doi.org/10.1371/journal.pone.0304175
Li, Y., Regan, M., Barham, T., Beeler Asay, G., Cohen, T., Hill, A., Horsburgh, C., Miller, J., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., & Menzies, N. (2024). Disparities in tuberculosis incidence by race and ethnicity among the U.S.-born population in the United States, 2011 to 2021: An analysis of national disease registry data. Annals of Internal Medicine, 177(4), 418-427. https://doi.org/10.7326/M23-2975
Regan, M., Barham, T., Li, Y., Swartwood, N., Beeler Asay, G., Cohen, T., Horsburgh, C., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., Winston, C., & Menzies, N. (2024). Risk factors underlying racial and ethnic disparities in tuberculosis diagnosis and treatment outcomes, 2011-19: A multiple mediation analysis of national surveillance data. Lancet Public Health, 9(8), e564-e572. https://doi.org/10.1016/S2468-2667(24)00151-8
Menzies, N., Swartwood, N., Cohen, T., Marks, S., Maloney, S., Chappelle, C., Miller, J., Beeler Asay, G., Date, A., Horsburgh, C., & Salomon, J. (2024). The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: A mathematical modelling study. Lancet Public Health, 9(8), e573-e582. https://doi.org/10.1016/S2468-2667(24)00150-6
Yin, X., Li, Y., Ronn, M., Li, S., Yuan, Y., Gift, T., Hsu, K., Salomon, J., Grad, Y., & Yaesoubi, R. (2024). Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis. PLOS Medicine, 21(7), e1004424. https://doi.org/10.1371/journal.pmed.1004424
Swartwood, N., Li, Y., Regan, M., Marks, S., Barham, T., Beeler Asay, G., Cohen, T., Hill, A., Horsburgh, C., Khan, A., McCree, D., Myles, R., Salomon, J., Self, J., & Menzies, N. (2024). Estimated health and economic outcomes of racial and ethnic tuberculosis disparities in US-born persons. JAMA Network Open, 7(9), e2431988. https://doi.org/10.1001/jamanetworkopen.2024.31988
Ekramnia, M., Li, Y., Haddad, M., Marks, S., Kammerer, J., Swartwood, N., Cohen, T., Miller, J., Horsburgh, C., Salomon, J., & Menzies, N. (2024). Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States. Epidemiology, 35(2), 164-173. https://doi.org/10.1097/EDE.0000000000001707
Hutton, D., Toy, M., Yang, D., Zhang, H., Handanagic, S., Armstrong, P., Wasley, A., Menzies, N., Pham, H., Salomon, J., & So, S. (2024). Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13982
Zhu, L., Thomas, W., Hagan, L., Randall, L., Rudolph, A., Young, A., Havens, J., Salomon, J., & Linas, B. (2024). Potential impact of curative and preventive interventions toward hepatitis C elimination in people who inject drugs-A network modeling study. International Journal of Drug Policy, (130), 104539. https://doi.org/10.1016/j.drugpo.2024.104539
Regan, M., Li, Y., Swartwood, N., Barham, T., Beeler Asay, G., Cohen, T., Hill, A., Horsburgh, C., Khan, A., Marks, S., Myles, R., Salomon, J., Self, J., & Menzies, N. (2024). Racial and ethnic disparities in diagnosis and treatment outcomes among US-born people diagnosed with tuberculosis, 2003–19: An analysis of national surveillance data. The Lancet Public Health, 9(1), e47-e56. https://doi.org/10.1016/S2468-2667(23)00276-1
Pham, T., Toy, M., Hutton, D., Thompson, W., Conners, E., Nelson, N., Salomon, J., & So, S. (2023). Gaps and disparities in chronic hepatitis B monitoring and treatment in the United States, 2016-2019. Medical Care, 61(4), 247-253. https://doi.org/10.1097/MLR.0000000000001825
Pham, T., Maria, N., Cheng, V., Nguyen, B., Toy, M., Hutton, D., Conners, E., Nelson, N., Salomon, J., & So, S. (2023). Gaps in prenatal hepatitis B screening and management of HBsAg positive pregnant persons in the United States. American Journal of Preventative Medicine, 65(1), 52-29. https://doi.org/10.1016/j.amepre.2023.01.041
Klaassen, F., Chitwood, M., Cohen, T., Pitzer, V., Russi, M., Swartwood, N., Salomon, J., & Menzies, N. (2023). Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021. Clinical Infectious Diseases, 76(3), e350–e359. https://doi.org/10.1093/cid/ciac438
Rönn, M., Menzies, N., & Salomon, J. (2023). Vaccination and voting patterns in the U.S.: Analysis of COVID-19 and flu surveys from 2010 to 2022. American Journal of Preventive Medicine, 65(3), 458-466. https://doi.org/10.1016%2Fj.amepre.2023.03.001
Li, Y., Rönn, M., Tuite, A., Chesson, H., Gift, T., Trikalinos, T., Testa, C., Bellerose, M., Hsu, K., Berruti, A., Malyuta, Y., Menzies, N., & Salomon, J. (2022). Estimated costs and quality-adjusted life-years lost due to N. gonorrhoeae infections acquired in 2015 in the United States: A modelling study of overall burden and disparities by age, race/ethnicity, and other factors. Lancet Regional Health Americas, 16. https://doi.org/10.1016/j.lana.2022.100364
Zhong, H., Brandeau, M., Yazdi, G., Wang, J., Nolen, S., Hagan, L., Thompson, W., Assoumou, S., Linas, B., & Salomon, J. (2022). Metamodeling for policy simulations with multivariate outcomes. Medical Decision Making, 42(7). https://doi.org/10.1177/0272989X221105079
Lee, K., You, S., Li, Y., Chesson, H., Gift, T., Berruti, A., Hsu, K., Yaesoubi, R., Salomon, J., & Rönn, M. (2022). Estimation of the lifetime quality-adjusted life years (QALYs) lost due to syphilis acquired in the United States in 2018. Clinical Infectious Diseases, 76(3), e810–e819. https://doi.org/10.1093/cid/ciac427
Kim, S., Cohen, T., Horsburgh, C., Miller, J., Hill, A., Marks, S., Li, R., Kammerer, J., Salomon, J., & Menzies, N. (2022). Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clinical Infectious Diseases, 74(9), 1594–1603. https://doi.org/10.1093/cid/ciab668
Yaesoubi, R., Cohen, T., Hsu, K., Gift, T., St Cyr , S., Salomon, J., & Grad, Y. (2022). Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics. PLoS Computational Biology, 18(2). https://doi.org/10.1371/journal.pcbi.1009842
Toy, M., Hutton, D., Harris, A., Nelson, N., Salomon, J., & So, S. (2022). Cost-effectiveness of one-time universal screening for chronic hepatitis B infection in adults in the United States. Clinical Infectious Diseases, 74(215), 210–217. https://doi.org/10.1093/cid/ciab405